PDI Healthcare

Prevantics® Device Swab & Strip

Interventional Care

Prevantics® Device

Swab & Strip

For disinfecting needleless access sites prior to use. Contains 3.15% (w/v) CHG and 70% (v/v) IPA solution. 


Fast Facts

5 second scrub time
5 second dry time
3.15% CHG/ 70% IPA formulation
Prevantics® Device Swab
Prevantics® Device Swab
Swab
  • Intuitive prep-pad design.
  • 1mL.
  • Each box contains 100 swabs.
SKU
B19600
Applicator Dimensions
3.125" x 1.125"
Packaging
10/100's
Prevantics® Device Strip
Prevantics® Device Strip
Strip
  • Hangs conveniently on an IV pole for point-of-care accessibility.
  • 8 swabs per strip (each box contains 20 strips)
  • Each strip comes with hang tab attached.
SKU
B123ST
Applicator Dimensions
3.125" x 1.125"
Packaging
10/160's

Features and Benefits

The first and only 3.15% (w/v) Chlorhexidine gluconate (CHG) and 70% (v/v) Isopropyl alcohol (IPA) solution to receive 510k clearance from the US Food and Drug Administration (FDA) for use in disinfecting needleless access sites prior to use.

  • Features a 5 second scrub time followed by 5 second dry time.
  • Contains 3.15% Chlorhexidine Gluconate and 70% Isopropyl Alcohol.  

 

Request your FREE sample kit!

  • Compliant with evidence-based recommendations from the following organizations:
    • US Centers for Disease Control and Prevention
    • Infusion Nurses Society
    • Society for Healthcare Epidemiology of America
    • The Joint Commission National Patient Safety Goals
    • Infectious Diseases Society of America
    • Association for Professionals in Infection Control and Epidemiology
    • Association for Vascular Access
       
  • 10 independent clinical studies demonstrating clinical efficacy of Prevantics® products.

Frequently Asked Questions

See All FAQs
Not necessarily. The Prevantics Device Swab can be used for both terminal disinfection of a needleless access site prior to use as well as in between each access. If clinicians follow all existing infection prevention and control measures for CLABSI prevention, such as hand hygiene, use of personal protective equipment, and use of chlorhexidine-based skin antiseptics, then the use of an alcohol impregnated cap may not be clinically indicated. This would be evaluated by ongoing surveillance of CLABSI rates.
The following evidence-based clinical guidelines support the use of the Prevantics Device Swab for disinfection of needless access sites prior to use: 1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC) 2. Standards of Practice, Infusion Nurses Society (INS) 3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA) 4. 2015 National Patient Safety Goals, The Joint Commission 5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA) 6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC)
For our EPA-regulated products, such as Sani-Cloth® brand products, room temperature is defined as an average temperature of 25◦ C (77◦ F) and within a temperature range of 15◦ C to 30◦ C (59◦ F to 86◦ F). For some of our FDA-regulated products, such as Prevantics® brand products, "controlled room temperature" indicates a temperature maintained thermostatically that encompasses the usual customary working environment of 20◦ C to 25◦ C (68◦ F to 77◦ F). SOURCE: USP 36-NF 31 General Notices and Requirements (August 1, 2013 First Supplements) Section 10.30.50. Room Temperature - "Room temperature" indicates the temperature prevailing in a working area. Section 10.30.60. Controlled Room Temperature